BNET Industries
- Private
Contact Information
NAICS Code Colleges, Universities, and Professional Schools: 611310
Recent Events
-
Report: JMU Continues H1N1 Prep
-
James Madison Inks New High-Tech Partnership
-
Infant Formula Company Teams With the University of Virginia Pediatrics Department...
-
University of Virginia president retiring
News & Analysis
Filter by
agent and university of virginia - All News and Analysis
VisualSonics Expands Functionality and Introduces Molecular Imaging Capabilities; Company will in-license University of Virginia contrast agent for use in cardiovascular research.
TORONTO, Jan 26, 2006 CCNMatthews via COMTEX -- Paving the way for its entry into the molecular imaging market, VisualSonics, the world's leading developer of high-resolution, ultrasound-based, in vivo micro-imaging systems, today announced it is i TORONTO, Jan 26, 2006 CCNMatthews via COMTEX -- Paving the...
VisualSonics Expands Functionality and Introduces Molecular Imaging Capabilities; Company will in-license University of Virginia contrast agent for use in cardiovascular research
TORONTO -- Paving the way for its entry into the molecular imaging market, VisualSonics, the world's leading developer of high-resolution, ultrasound-based, in vivo micro-imaging systems, today announced it is in-licensing a contrast agent for the quantification of myocardial perfusion in preclinical studies from the University of Virginia. The contrast agent...
Chemical Agent Sensor Firm in UVA's Darden School Progressive Incubator Developing Prototype
Business Editors/Defense Writers CHARLOTTESVILLE, Va.--BUSINESS WIRE--Oct. 8, 2001 A Charlottesville-based firm is developing a new generation of chemical agent detectors using innovations originating from NASA and University of Virginia labs. Avir, LLC (www.avirsensors.com) is currently in discussions with the United States Navy on possible use of its...
GeNeuron announces issuance of United States patent.(Brief Article)
GeNeuron Therapeutics, Inc. (Charlottesville, VA: 804-979-5450), a leading developer of biologically enhanced medical devices, announced the issuance of United States Patent 6,096,021, Flow Arrest, Double Balloon Technique for Occluding Aneurysms or Blood Vessels. "This patent gives GeNeuron an important platform for the delivery...
- 1


